Prescribing considerations in the use of oral medication in Parkinson's disease

Abstract

The aim of this article is to consider and support the rationale for prescribing decisions throughout the Parkinson's disease trajectory. The authors will discuss the challenges of managing both motor and non-motor features of Parkinson's disease mindful of potential complications attributable to both progression and medications used. This will include motor fluctuations and impulse control behaviours, which can adversely affect quality of life. The Parkinson's specialist will need to consider a treatment regimen that optimises symptom control while limiting the potential adverse effects of medications. This article will provide an overview of oral medications used throughout the recognised stages of Parkinson's disease.